Genstar Capital to Consider $4 Billion Sale of TekniPlex
- Private equity firm agreed to take control of the firm in 2017
- TekniPlex makes health-care, pharma and food-industry goods
TekniPlex employs more than 7,000 people globally across its health-care and consumer businesses.
Source: TekniPlexThis article is for subscribers only.
Genstar Capital, a San Francisco-based private equity firm, is considering a sale of TekniPlex that could value the manufacturing group at more than $4 billion, according to people familiar with the matter.
The buyout firm is working with an adviser on an auction process for the company, said the people, who asked not to be identified because they weren’t authorized to speak publicly. The Wayne, Pennsylvania-based company is expected to attract interest from peers and other private equity firms, the people said.